Insider Selling: 908 Devices Inc. (NASDAQ:MASS) CFO Sells $23,952.24 in Stock

908 Devices Inc. (NASDAQ:MASS) CFO Joseph H. Iv Griffith sold 10,236 shares of 908 Devices stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $2.34, for a total value of $23,952.24. Following the transaction, the chief financial officer now directly owns 109,870 shares in the company, valued at $257,095.80. The trade was a 8.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

908 Devices Stock Performance

908 Devices stock opened at $2.55 on Friday. The stock’s 50 day moving average price is $2.35 and its two-hundred day moving average price is $3.26. 908 Devices Inc. has a 52-week low of $1.81 and a 52-week high of $7.91.

Wall Street Analysts Forecast Growth

MASS has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 908 Devices in a research note on Saturday, February 1st. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Stephens reiterated an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a research report on Wednesday, January 15th. Stifel Nicolaus lowered their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Finally, Leerink Partners reaffirmed a “market perform” rating and set a $4.00 price target (down previously from $12.00) on shares of 908 Devices in a research report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $5.33.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of MASS. SG Americas Securities LLC acquired a new position in shares of 908 Devices during the third quarter valued at about $36,000. B. Riley Wealth Advisors Inc. acquired a new stake in 908 Devices in the 3rd quarter valued at $45,000. Townsquare Capital LLC bought a new stake in 908 Devices during the 3rd quarter valued at $50,000. Drive Wealth Management LLC acquired a new position in 908 Devices during the third quarter worth $50,000. Finally, Concurrent Investment Advisors LLC bought a new position in shares of 908 Devices in the fourth quarter valued at $52,000. 88.06% of the stock is owned by institutional investors.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.